Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs SABRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs SABRIL: Safety Overview

Metric ROZANOLIXIZUMAB SABRIL
Total FAERS Reports 303 772
Deaths Reported 9 53
Death Rate 3.0% 6.9%
Hospitalizations 114 180
Average Patient Age 61.3 yrs 11.0 yrs
% Female Patients 60.9% N/A
Manufacturer UCB, Inc. N/A
Route SUBCUTANEOUS N/A